Corrigendum to: Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of Skp2
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Compuscript Ltd
2023-05-01
|
Series: | Acta Materia Medica |
Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2023-1001 |